Loading…
Lucid Diagnostics Inc. is projected to rise to $1.18 by 2027, a +14% move from its current price of $1.04. LUCD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.01 | $1.04 | $1.07 | -0.04% |
| May 30 | $0.9921 | $1.04 | $1.09 | -0.07% |
| May 31 | $0.9814 | $1.04 | $1.10 | -0.11% |
| Jun 1 | $0.9724 | $1.04 | $1.11 | -0.15% |
| Jun 2 | $0.9646 | $1.04 | $1.12 | -0.18% |
| Jun 3 | $0.9575 | $1.04 | $1.12 | -0.22% |
| Jun 4 | $0.951 | $1.04 | $1.13 | -0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.951 | $1.04 | $1.13 | -0.26% |
| Week 2 | $0.915 | $1.03 | $1.17 | -0.51% |
| Week 3 | $0.8878 | $1.03 | $1.20 | -0.77% |
| Week 4 | $0.8651 | $1.03 | $1.22 | -1.03% |
| Week 5 | $0.8454 | $1.03 | $1.25 | -1.28% |
| Week 6 | $0.8277 | $1.02 | $1.27 | -1.53% |
| Week 7 | $0.8116 | $1.02 | $1.29 | -1.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with GERD who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma.
The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients.
The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
Lucid Diagnostics Inc. (LUCD) is currently priced at $1.07 and has a market capitalization of $204.11M. Its rank is 3834.
The near-term price outlook is reflected by a bullish technical picture, with recent momentum supported by a bullish sentiment.
The forecast suggests a longer-term bullish trajectory, with the average forecast price rising from $1.07 in 2026 to $1.68 by 2030, then to $4.10 by 2040 and reaching $7.30 by 2050.
A major floor 35.6% below — a decisive break under it would weaken the trend.
The nearest floor, 8.9% below — buyers have tended to step in here.
The nearest ceiling, 35.6% above — a clean break opens room to run.
A major ceiling 53.4% above — clearing it would confirm fresh momentum.
Key LUCD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LUCD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.04 | Sell | $1.05 | Sell |
| MA 10 | $1.02 | Buy | $1.04 | Buy |
| MA 20 | $1.04 | Buy | $1.05 | Sell |
| MA 50 | $1.14 | Sell | $1.12 | Sell |
| MA 100 | $1.21 | Sell | $1.16 | Sell |
| MA 200 | $1.16 | Sell | $1.17 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.26 | Neutral |
| Stoch RSI (14) | 66.21 | Neutral |
| CCI (20) | 5.30 | Neutral |
| Williams %R (14) | -42.94 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 0.97 | Buy |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 57.06 | Neutral |
| TRIX (15) | -0.61 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 51.89 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.09 | Sell |
| ADX (14) | 21.33 | Sell |
| ATR (14) | 0.03 | Info |
Technical picture for the next 30 days shows a BULLISH sentiment. The RSI14 is 50, with a SMA50 of $1.15 and a SMA200 of $1.16. Support is at $0.947 and resistance at $1.41, framing a thirty-day range of $0.8724 to $1.31.
This setup suggests the near term could see upside within the defined range, though volatility remains a consideration given the stock’s overall market dynamics.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.947 | $1.04 | $1.35 | 0% | Neutral | |
| $0.9201 | $1.18 | $1.62 | +14% | Neutral | |
| $0.8858 | $1.18 | $1.68 | +13% | Neutral | |
| $0.8733 | $1.19 | $1.76 | +15% | Neutral | |
| $1.09 | $1.53 | $2.32 | +47% | Bullish | |
| $1.24 | $1.79 | $2.78 | +72% | Bullish | |
| $1.37 | $2.01 | $3.19 | +93% | Bullish | |
| $1.50 | $2.24 | $3.63 | +116% | Bullish | |
| $1.42 | $2.16 | $3.57 | +108% | Bullish | |
| $1.51 | $2.34 | $3.93 | +125% | Bullish | |
| $2.13 | $3.61 | $6.49 | +247% | Bullish | |
| $3.12 | $6.16 | $12.27 | +493% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.947 | $1.04 | $1.23 | +0.00% |
| June 2026 | $0.89 | $1.05 | $1.27 | +0.95% |
| July 2026 | $0.8439 | $1.01 | $1.24 | -4.21% |
| August 2026 | $0.8234 | $0.989 | $1.23 | -1.65% |
| September 2026 | $0.8429 | $1.02 | $1.28 | +3.05% |
| October 2026 | $0.8398 | $1.02 | $1.30 | +0.24% |
| November 2026 | $0.8244 | $1.01 | $1.29 | -1.31% |
| December 2026 | $0.8536 | $1.05 | $1.35 | +4.07% |
Click any year to see its month-by-month LUCD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Lucid Diagnostics Inc.'s 2026 outlook centres on $1.04, within a $0.947 to $1.35 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, LUCD could reach as high as $1.62, with a base case around $1.18 and support toward $0.9201 — roughly +14% from $1.04. Price action looks broadly range-bound.
Expect LUCD to range from $0.8858 to $1.68 through 2028. The $1.18 average target implies a +13% move from current prices. That is 0% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The LUCD price prediction for 2029 points to an average of $1.19 (low $0.8733, high $1.76) — a potential gain of +15% on today's $1.04. Price action looks broadly range-bound.
In 2030, LUCD is projected to trade between $1.09 and $2.32, averaging $1.53 — a potential gain of +47% from today's $1.04. That is up +28% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Lucid Diagnostics Inc.'s 2031 outlook centres on $1.79, within a $1.24 to $2.78 range. That is up +17% on the projected 2030 average. That marks a +72% change versus current levels. Momentum favours further upside here.
By 2032, LUCD could reach as high as $3.19, with a base case around $2.01 and support toward $1.37 — roughly +93% from $1.04. Buyers look set to stay in control over this stretch.
Expect LUCD to range from $1.50 to $3.63 through 2033. The $2.24 average target implies a +116% move from current prices. That is up +12% on the projected 2032 average. Momentum favours further upside here.
The LUCD price prediction for 2034 points to an average of $2.16 (low $1.42, high $3.57) — a potential gain of +108% on today's $1.04. Buyers look set to stay in control over this stretch.
In 2035, LUCD is projected to trade between $1.51 and $3.93, averaging $2.34 — a potential gain of +125% from today's $1.04. That is up +8% on the projected 2034 average. Momentum favours further upside here.
Lucid Diagnostics Inc.'s 2040 outlook centres on $3.61, within a $2.13 to $6.49 range. That is up +54% on the projected 2035 average. That marks a +247% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, LUCD could reach as high as $12.27, with a base case around $6.16 and support toward $3.12 — roughly +493% from $1.04. Momentum favours further upside here.
Investing $1,000 in LUCD today (≈ 961.538462 LUCD) could be worth
$5,927.57
+$4,927.57 (+493%) by 2050 · US Dollar
Based on the average projected LUCD price of $6.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LUCDwould be worth at today's price.
$1,000 invested in LUCD on May 27, 2025 (≈ 657.894745 LUCD) would be worth
$684.21
-$315.79 (-31.6%) today · 0.68× · US Dollar
Based on a LUCD entry price of $1.52 vs. today's $1.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1 | $1,040 | +4.0% |
| 1 month ago | $1.06 | $981.13 | -1.9% |
| 3 months ago | $1.47 | $707.48 | -29.3% |
| 6 months ago | $1.06 | $981.13 | -1.9% |
| 1 year ago | $1.52 | $684.21 | -31.6% |
| All time (4.6y) ago | $11.76 | $88.44 | -91.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LUCD forecast.
Our base-case forecast reaches $2.10 around 2033.
Implied market cap at $2.10: $400.59M
The multi-year forecast presents a bullish trajectory, with a progression of yearly averages and corresponding ROIs. In 2026, the min, avg, and max are $0.947, $1.07, and $1.41 with ROI 0 and a NEUTRAL sentiment. By 2027 the avg is $1.24 (min $0.9689, max $1.68) with ROI 15.7 and NEUTRAL sentiment, and by 2028 the avg is $1.26 (min $0.9531, max $1.78) with ROI 17.4.
In 2029 the avg climbs to $1.31 with ROI 22.7 and a BULLISH stance, and by 2030 the avg is $1.68 with ROI 56.7 and BULLISH sentiment. The forecast continues higher through 2031 ($1.97, ROI 83.9), 2032 ($2.22, ROI 107.3), 2033 ($2.47, ROI 130.8), 2034 ($2.42, ROI 125.9), and 2035 ($2.64, ROI 146.5).
Longer horizon targets include 2040 with an avg of $4.10 and ROI 283.1, and 2050 with an avg of $7.30 and ROI 581.9, both coded as BULLISH. These numbers illustrate a sustained, but uncertain, upward path; the figures are estimates, not guarantees, and reflect market and company developments over time.
Tap a question to reveal the answer.
2030 avg price is $1.68 with min $1.21 and max $2.51; ROI 56.7%; sentiment BULLISH.
Forecasts show a bullish trajectory with 2040 avg $4.10 and 2050 avg $7.30; ROI up to 581.9%; but these are estimates and not guaranteed.
Yes, the forecast max for 2040 is $7.23 and the max for 2050 is $14.18, so a $5 level is within the projected range, though not guaranteed.
Current price is $1.07 and market cap is $204.11M.
2040 min $2.48, avg $4.10, max $7.23; ROI 283.1%; sentiment BULLISH.
Lucid Diagnostics Inc. Community Discussion
0Share your Lucid Diagnostics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.